Literature DB >> 8921275

The glutamate transport inhibitor L-trans-pyrrolidine-2,4-dicarboxylate indirectly evokes NMDA receptor mediated neurotoxicity in rat cortical cultures.

R Blitzblau1, S Gupta, S Djali, M B Robinson, P A Rosenberg.   

Abstract

Because of the well-documented importance of glutamate uptake in protecting neurons against glutamate toxicity, we were interested in testing the effects of L-trans-pyrrolidine-2,4-dicarboxylate (PDC) on rat cortical cultures. This compound is a substrate for glutamate transporters and is a potent glutamate transport inhibitor that does not interact significantly with glutamate receptors. Using a 30 min exposure, and assessing neuronal survival after 20-24 h, PDC was neurotoxic in conventional astrocyte-rich cortical cultures, with an EC50 in these cultures of 320 +/- 157 microM. In astrocyte-poor cultures, an EC50 for PDC of 50 +/- 5 microM was determined. The neurotoxicity of PDC in both astrocyte-rich and astrocyte-poor cultures was blocked by the NMDA antagonist MK-801, but not by the non-NMDA receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX). We tested the possibility that the neurotoxicity of PDC might be due to release of excitatory amino acids using several approaches. After pre-loading cells with the non-metabolizable analogue of glutamate, [3H]-D-aspartate, first we demonstrated that PDC caused significant efflux of [3H]-D-aspartate. This effect of PDC was dependent upon extracellular sodium. In contrast with glutamate neurotoxicity, PDC neurotoxicity was inhibited by removal of extracellular sodium. In the presence of 1 mM PDC, sodium caused neurotoxicity with an EC50 of 18 +/- 7.6 mM. Tetrodotoxin had no effect on either PDC neurotoxicity or on PDC-evoked [3H]-D-aspartate release. PDC-evoked release of [3H]-D-aspartate was demonstrable in astrocyte cultures with no neurons present. PDC also evoked release of endogenous glutamate. Finally, the neurotoxicity of PDC was blocked by coincubation with glutamate-pyruvate transaminase plus pyruvate to degrade extracellular glutamate. These results demonstrate the neurotoxicity of PDC, and suggest that the mechanism of this toxicity is the glutamate transporter-dependent accumulation of glutamate in the extracellular space.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8921275     DOI: 10.1111/j.1460-9568.1996.tb01328.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  22 in total

1.  NMDA and glutamate evoke excitotoxicity at distinct cellular locations in rat cortical neurons in vitro.

Authors:  J D Sinor; S Du; S Venneti; R C Blitzblau; D N Leszkiewicz; P A Rosenberg; E Aizenman
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

2.  Glia mechanisms in mood regulation: a novel model of mood disorders.

Authors:  Younglim Lee; Denise Gaskins; Amit Anand; Anantha Shekhar
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

3.  Decreased glutamate transport enhances excitability in a rat model of cortical dysplasia.

Authors:  Susan L Campbell; John J Hablitz
Journal:  Neurobiol Dis       Date:  2008-07-15       Impact factor: 5.996

Review 4.  Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease.

Authors:  Kou Takahashi; Joshua B Foster; Chien-Liang Glenn Lin
Journal:  Cell Mol Life Sci       Date:  2015-06-02       Impact factor: 9.261

5.  Marked synergism between mutant SOD1 and glutamate transport inhibition in the induction of motor neuronal degeneration in spinal cord slice cultures.

Authors:  Hong Z Yin; John H Weiss
Journal:  Brain Res       Date:  2012-02-09       Impact factor: 3.252

6.  Glutamate induces rapid upregulation of astrocyte glutamate transport and cell-surface expression of GLAST.

Authors:  S Duan; C M Anderson; B A Stein; R A Swanson
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

7.  Targeting a Potassium Channel/Syntaxin Interaction Ameliorates Cell Death in Ischemic Stroke.

Authors:  Chung-Yang Yeh; Ashlyn M Bulas; Aubin Moutal; Jami L Saloman; Karen A Hartnett; Charles T Anderson; Thanos Tzounopoulos; Dandan Sun; Rajesh Khanna; Elias Aizenman
Journal:  J Neurosci       Date:  2017-05-08       Impact factor: 6.167

8.  Comparison of effects of DL-threo-beta-benzyloxyaspartate (DL-TBOA) and L-trans-pyrrolidine-2,4-dicarboxylate (t-2,4-PDC) on uptake and release of [3h]D-aspartate in astrocytes and glutamatergic neurons.

Authors:  H S Waagepetersen; K Shimamoto; A Schousboe
Journal:  Neurochem Res       Date:  2001-06       Impact factor: 3.996

9.  Evaluation of drugs acting at glutamate transporters in organotypic hippocampal cultures: new evidence on substrates and blockers in excitotoxicity.

Authors:  Ross D O'Shea; Melissa V Fodera; Karina Apricó; Yvette Dehnes; Niels C Danbolt; Duncan Crawford; Philip M Beart
Journal:  Neurochem Res       Date:  2002-02       Impact factor: 3.996

10.  Glutamate dehydrogenase 1 and SIRT4 regulate glial development.

Authors:  Daniel Komlos; Kara D Mann; Yue Zhuo; Christopher L Ricupero; Ronald P Hart; Alice Y-C Liu; Bonnie L Firestein
Journal:  Glia       Date:  2012-12-22       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.